Summary by Futu AI
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted several share repurchases from March 11 to April 15, 2024. According to the Company's Next Day Disclosure Report, the Company repurchased a total of millions of shares of A-shares during the above period, with detailed records of the number of shares repurchased and the date of the change. The repurchase price presents a different degree of discount or premium compared to the market price. The last repurchase took place on April 15, 2024, on which day the company repurchased 473,700 shares of A-shares for a total amount of RMB20,049,239. The repurchase of the series of shares is carried out in accordance with the relevant rules at the Shanghai Stock Exchange, and the company confirms that all transactions comply with local regulations.